J9352 Injection trabectedin 0.1mg
Also known as: trabectedin, Yondelis
Injection of trabectedin, 0.1 milligram. A marine alkaloid nucleoside analog for soft tissue sarcoma and ovarian cancer.
In Plain Language
sarcoma cancer injection; ovarian cancer treatment
Clinical Context
Used for advanced soft tissue sarcoma and relapsed ovarian cancer. Binds DNA and disrupts transcription factors.
RVU Information
CPT J9352 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9352?
CPT J9352 (Injection trabectedin 0.1mg) is a J Codes (Drugs) code. Injection of trabectedin, 0.1 milligram. A marine alkaloid nucleoside analog for soft tissue sarcoma and ovarian cancer.
How is J9352 administered?
CPT J9352 is administered by a healthcare provider, typically via injection or infusion. Used for advanced soft tissue sarcoma and relapsed ovarian cancer. Binds DNA and disrupts transcription factors. It is used by Oncology, Gynecology, Surgery.
When is CPT J9352 used?
Used for advanced soft tissue sarcoma and relapsed ovarian cancer. Binds DNA and disrupts transcription factors.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.